misterhonkers.com

Only men develop prostate cancer. Inspirational stories about four men who have survived prostate cancer. Over the past two decades, new techniques to diagnose prostate cancer early in its progression have boosted the survival rate for men with all stages of prostate cancer from 67 percent to 92 percent. A continually updated listing of Memorial Sloan-Kettering’s current clinical trials for prostate cancer. These include surgery, systemic therapy, and radiation therapy, as well as delayed treatment or watchful waiting. Several modes of treatment are employed to treat prostate cancer. Memorial Sloan-Kettering’s physicians develop a fully individualized prostate health treatment plan for each patient based on a complete picture of his disease — the severity of his cancer and the risks it poses, his life expectancy, other medical conditions, lifestyle considerations, and personal preferences. Two standard screening examinations are the first step in diagnosing prostate cancer, whether or not symptoms are present. Others may notice one or more symptoms. History the first indication that they may have the disease is often an abnormal finding on a routine screening exam.